HomeNewsBusinessForbes enters into exclusive buyout talks with investor group

Forbes enters into exclusive buyout talks with investor group

Forbes had been seeking at least $800 million in a sale, The New York Times reported earlier on Wednesday

November 10, 2022 / 06:31 IST
Story continues below Advertisement

Business news and information publisher Forbes said on Wednesday it has entered into "exclusive discussions" with an investor consortium for the sale of the company.

The move comes months after the publisher pulled out of a deal to go public through a special purpose acquisition company (SPAC). In August, it said it hired Citigroup to manage the sale.

Story continues below Advertisement

The consortium comprises of family offices and global investors, a Forbes spokesman said in a statement, but did not disclose the value of the deal.

Forbes had been seeking at least $800 million in a sale, The New York Times reported earlier on Wednesday, citing two people familiar with the matter.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show